Cargando…
Patients’ self-management of adverse events and patient-reported outcomes in advanced renal cell carcinoma treated with targeted therapies: A prospective, longitudinal, observational study
BACKGROUND: Early intervention to reduce the impact of adverse events (AEs) may improve patients’ quality of life and enable optimal treatment duration. METHODS: This nationwide, multicenter, prospective, longitudinal, 1-year observational study investigated patients’ self-management of AEs associat...
Autores principales: | Hong, Sung-Hoo, Chung, Ho Seok, Seo, Ill-Young, Kwon, Tae Gyun, Jeong, Hyeon, Chung, Jae-Il, Jeon, Seung Hyun, Park, Jae Young, Ha, Hong Koo, Chung, Byung-Ha, Song, Wan, Kim, Young-Joo, Kim, Sang-Hee, Lee, Jee-Sun, Lee, Juneyoung, Chung, Jinsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758263/ https://www.ncbi.nlm.nih.gov/pubmed/36525150 http://dx.doi.org/10.1186/s41687-022-00532-0 |
Ejemplares similares
-
Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study
por: Kim, Sung Han, et al.
Publicado: (2015) -
Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study
por: Kim, Sung Han, et al.
Publicado: (2017) -
Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry
por: Kim, Jung Kwon, et al.
Publicado: (2019) -
Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database
por: Park, Jae Young, et al.
Publicado: (2020) -
Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)